Section 14(4) of the Patents Act explicitly provides for protection of a new use of a known substance or composition if it was not previously disclosed for use in surgery, therapy or diagnosis (ie, first medical use). Protection of substances or compositions claimed under this format is restricted to the substance or composition when presented or packaged for use.
The rest of this article is locked for subscribers only. Please login to continue reading.
If you don't have a login, you will need to purchase a subscription to gain access to this article, including all our online content. Please use this link and follow the steps.
For multi-user price options, or to check if your company has an existing subscription to us that we can add you to for FREE, please email Atif Choudhury at achoudhury@worldipreview.com
Oon Yen Yen,Henry Goh, medical claims, patent, UKIPO, EPO, MyIPO
